Hepatitis Treatments
Share
Follow Us
What is…?
What is Mavyret? (glecaprevir and pibrentasvir)
What is Vosevi? (sofosbuvir, velpatasvir and voxilaprevir)
What is Zepatier? (elbasvir and grazoprevir)
What is Epclusa? (sofosbuvir/velpatasvir)
What is Daklinza? (daclatasvir)
What is Technivie? (ombitasvir, paritaprevir and ritonavir)
What is Viekira Pak™ (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets)?
What Is Harvoni® (ledipasvir and sofosbuvir)?
What is Ally-1? (daclatasvir, sofosbuvir and ribavirin)
What is Unity-1? (daclatasvir, asunaprevir, beclabuvir)
What Is Sovaldi™ (sofosbuvir)?
What is Victrelis™ (boceprevir)? TO BE DISCONTINUED IN 2015
What is Incivek™ (telaprevir)? NO LONGER AVAILABLE
Learn about Hepatitis C treatments by genotype.
Older Articles and Clinical Studies
Ribavirin approved for combo treatment
Ribavirin Interferon Combination with phlebotomy
Ribavirin Treatment alone or in combination with Interferon
IFN Alfa-2b Plus Ribavirin Combination Increases Sustained Response Rate
Phase III results of Interferon & Rebetol
FDA approves Rebetron Combination Therapy
Long term efficacy of Ribavirin plus interferon alfa
Interferon, Ribavirin and Actigall
Hepatitis C: Important Treatment Advance: Interview with Douglas Dieterich, MD
Schering Submits Supplemental NDA for REBETRON(TM)
New Therapy Packs Powerful One-Two Punch Against HCV
Hepatitis C Virus Dynamics In Vivo: Effect of Ribavirin and Interferon Alfa on Viral Turnover
Treatment response in chronic Hepatitis C. Content of virus in serum is decisive for the outcome
Ribavirin monotherapy in patients with chronic Hepatitis C
Ribavirin in Hepatitis C related cryoglobulinemia
Ribavirin in Hepatitis C related cryoglobulinemia
Hepatitis C Virus Dynamics In Vivo: Effect of Ribavirin and Interferon Alfa on Viral Turnover
Quantification of Serum Hepatitis C Virus RNA
Warnings Placed On Rebetron Hepatitis Therapy
Learn about new research regarding Hepatitis C Treatments.
